Intensity Therapeutics, Inc. (INTS) Q1 2024 Earnings
INTS·Reported May 9, 2024·Before market open
Diluted EPS came in at $-0.34.
Diluted EPS
$-0.34
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Intensity Therapeutics, Inc.'s Q1 2024 earnings report.
Intensity Therapeutics, Inc. (INTS) reported Q1 2024 earnings on May 9, 2024 before market open.
Intensity Therapeutics, Inc. reported diluted EPS of $-0.34 for Q1 2024.
You can read the 10-Q periodic report (0001567264-24-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.